SCHEMBL27270179

SCHEMBL27270179

COC(=O)C1OC(OC2C(O)C(CO)OC(OC)C2NC(C)=O)C(O)C(O)C1O

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 7/20 0.50
▸ LGALS8 O00214 3/20 0.50
▸ LGALS4 P56470 1/20 0.50
▸ LGALS7; LGALS7B P47929 2/20 0.48
▸ LGALS1 P09382 1/20 0.48
▸ LGALS9 O00182 2/20 0.47
▸ CD69 Q07108 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ MAPK1 P28482 2/20 0.43
▸ PTN P21246 1/20 0.41
▸ MDK P21741 1/20 0.41
▸ BDNF P23560 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15333778 0.91 LGALS3 (0.58) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL20121276 0.91 LGALS3 (0.58) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL20122239 0.91 LGALS3 (0.58) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL23336380 0.89 LGALS3 (0.48) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL23490863 0.87 LGALS3 (0.48) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL23057244 0.86 LGALS3 (0.52) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL24495336 0.86 LGALS3 (0.52) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
SCHEMBL23490870 0.86 CD69 (0.48) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
Dermatan SCHEMBL13472480 0.85 LGALS3 (0.49) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1
Dermatan SCHEMBL12691925 0.85 LGALS3 (0.49) LGALS3LGALS8LGALS4LGALS7; LGALS7BLGALS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240219372-A1 ANALYTICAL METHOD FOR GLYCOSAMINOGLYCANS JCR PHARMACEUTICALS CO., LTD. (JP) 2024-07-04 — — US disclosed
Send feedback